There were no differences in quality of life, symptoms, hospital admissions or mortality between a group of patients with pulmonary disease and low oxygen levels in the blood that received oxygen therapy at home for 24 hours a day, and a group that received the same therapy for 15 hours a day, according to a study from Lund University in Sweden.
Otsuka’s ADHD asset succeeds in registrational trials with children and teens
Otsuka Pharmaceutical’s ADHD drug candidate has met its goal in a pair of Phase III trials focused on children and teens with the neurodevelopmental condition,
October 28, 2023